The oral transmucosal drugs market is witnessing remarkable growth as healthcare providers and patients increasingly prefer non-invasive and rapid-onset drug delivery systems. Valued at USD 46.48 billion in 2023, the market is expected to reach USD 49.83 billion in 2024 and expand at a CAGR of 7.3%, ultimately achieving USD 87.86 billion by 2032. Oral...